The following Bill of Lading record outlines a container shipment imported into the US by BREAKTHRU BEVERAGE. This shipment is registered as coming from DIAGEO SCOTLAND LTD via Anvers,Belgium with logistic notifications handled by TRANS AMERICAN CHB, INC. Manifest records show a quanitity of 1081 CAS with a total weight of 15242 Kilograms arrived on 2020-01-28 via the vessel MSC ANTONIA to the port of New York/Newark Area, Newark, New Jersey. Cargo includes products identified as net weight: 820.800 kilograms commodity code 22083071 jw black 20cl 12y 24x01 abv 40.00%.
| Carrier Code | MEDU |
| Vessel | MSC ANTONIA [LR] |
| Departure Port | Anvers,Belgium |
| Landing Port | New York/Newark Area, Newark, New Jersey |
| Manifest Qty | 1081 CAS |
| Manifest Weight | 15242 Kilograms |
| Manifest Dimension | 25 Cubic Meters |
| Place of Receipt | GRANGEMOUTH |
| Port of Detination | Chicago, Illinois |
| Conveyance ID | 9398216 [IMO Number/Lloyds Number] |
| Transportation Mode | Vessel, containerized |
| Arrival Date | 2020-01-28 |
| Container # | Pieces | Description |
|---|---|---|
| MEDU4190690 | 1 | NET WEIGHT: 820.800 KILOGRAMS COMMODITY CODE 22083071 JW BLACK 20CL 12Y 24X01 ABV 40.00% |
| MEDU4190690 | 2 | NET WEIGHT: 1871.760 KILOGRAMS COMMODITY CODE 22083030 OBAN 75CL 14Y 12X01 AB V43.00% |
| MEDU4190690 | 168 | NET WEIGHT: 716.688 KILOGRAMS COMMODITY CODE 22083071 JW GOLD RSV 75CL 06X01 ABV40.00 % SHIPPER'S REFERENCE NUMBER: 6468639/0111560 379 EXPORTER'S REFERENCE NUMBER: 19480354040 |
| MEDU4190690 | 198 | NET WEIGHT: 832.788 KILOGRAMS COMMODITY CODE 22083030 LAGAVULIN 8YO 75CL 8Y 06X01 ABV4 8.00% |
| MEDU4190690 | 315 | NET WEIGHT: 3587.220 KILOGRAMS COMMODITY CODE 22083071 BUCHANAN DELUXE 1L 12Y 12X01 AB V40.00% |
| MEDU4190690 | NA PO: 4903606705 CUSTOMER PO: 4500746749 FDA PC: 21 CFR 170.3 (N)(2) SAME NA PO: 4903606705 CUSTOMER PO: 4500746749 FDA PC: 21 CFR 170.3 (N)(2) SAME NA PO: 4903606705 CUSTOMER PO: 4500746749 FDA PC: 21 CFR 170.3 (N)(2) | |
| MEDU4190690 | SAME SAME NA PO: 4903606705 CUSTOMER PO: 4500746749 FDA PC: 21 CFR 170.3 (N)(2) SAME NA PO: 4903606705 CUSTOMER PO: 4500746749 FDA PC: 21 CFR 170.3 (N)(2) SAME | |
| MEDU4190690 | NA PO: 4903606705 CUSTOMER PO: 4500746749 FDA PC: 21 CFR 170.3 (N)(2) SAME NA PO: 4903606705 CUSTOMER PO: 4500746749 FDA PC: 21 CFR 170.3 (N)(2) SAME NA PO: 4903606705 CUSTOMER PO: 4500746749 FDA PC: 21 CFR 170.3 (N)(2) | |
| MEDU4190690 | SAME SAME NA PO: 4903606705 CUSTOMER PO: 4500746749 FDA PC: 21 CFR 170.3 (N)(2) SAME NA PO: 4903606705 CUSTOMER PO: 4500746749 FDA PC: 21 CFR 170.3 (N)(2) SAME |
| Master BOL | House BOL | Voyage Number | Bill Type | Manifest # | Update / Run Date |
|---|---|---|---|---|---|
| MEDUUK834502 | () | 003W | In-bond Automated | 1 | 2020-01-20 / 2020-01-29 |